Liver Engraftment
Liver Engraftment - Related Videos
05:27
In Vivo Imaging of Liver Spheroids Engrafted in the Anterior Chamber of the Mouse Eye
0 Views •
2024
Here, we describe a platform that allows noninvasive in vivo imaging of liver spheroids engrafted in the anterior chamber of the mouse eye. The workflow spans from generating spheroids from primary liver cells to transplantation into the mouse eye and in vivo imaging at cellular resolution by confocal microscopy.
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
0 Views •
Cited by 1 •
2018
Mantle cell lymphoma (MCL) is a difficult to treat B cell disorder and it is equally difficult to establish a xenograft mouse model of primary MCL to study and develop therapeutics. Here, we describe the successful establishment of MCL xenografts in mice to help understand its underlying biology.
04:36
Adenocarcinoma Engraftment: A Method to Implant Cancer Cells into the Murine Lungs
0 Views •
2023
This video describes a method to engraft lung adenocarcinoma cells in murine lungs by preconditioning the airways with fibrosis-inducing agent–bleomycin. This method significantly enhances orthotopic engraftment of lung cancer cells into murine...
12:35
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
0 Views •
Cited by 14 •
2011
The study of liver sinusoidal endothelial cells (SECs) must be performed with primary cells obtained from the animal as no cell lines exist. This method relies on liver digestion and differential centrifugation for SEC purification for subsequent culturing and experimentation.
08:15
Tracking Dynamics of Muscle Engraftment in Small Animals by In Vivo Fluorescent Imaging
0 Views •
Cited by 4 •
2009
We describe an in vivo fluorescence imaging protocol to monitor muscle regeneration by GFP-labeled myoblasts after transplantation into skeletal muscles of both healthy and dystrophic mice. This protocol can be adapted to study muscle regeneration by transplantation of other types of cells and in other muscular conditions as well.
FAQs
Successful liver engraftment depends on how well transplanted cells or tissue interact with the recipient’s hepatic microenvironment. Donor cells must adhere to the liver, access blood flow, and withstand immune-mediated injury. These conditions determine whether the graft remains viable long enough to proliferate, repopulate damaged tissue, and contribute to liver function.
Immune-mediated injury can damage donor cells before they become established in the recipient liver. Engraftment therefore requires transplanted material to evade or withstand this injury while maintaining viability and function. The extent of immune-related damage influences cell retention and helps explain why survival after delivery is an important outcome in transplantation biology.
Initial cell survival alone may not restore a damaged liver. Donor cells must also proliferate or repopulate affected tissue so that their contribution extends beyond temporary retention. This expansion is especially relevant when researchers evaluate whether transplanted hepatocytes, stem cell-derived material, or organoid therapies can support functional repair rather than simply remain present.
Vascular integration links transplanted cells or tissue with blood flow in the recipient liver. Access to that circulation is one of the conditions donor material must achieve after delivery, alongside adhesion and resistance to immune injury. Researchers examine vascular integration because it helps indicate whether transplanted material has become functionally connected to the hepatic environment.
Researchers assess liver engraftment by examining cell retention, vascular integration, and restoration of metabolic activity. Together, these measurements distinguish simple persistence from broader biological integration and functional contribution. The resulting evidence helps determine whether a treatment has established donor material successfully and whether it may support repair of damaged hepatic tissue.
Liver engraftment is studied in hepatocyte transplantation, stem cell therapies, organoid therapies, and experimental models of liver repair. These settings allow researchers to examine how transplanted material behaves within damaged liver tissue and whether it contributes to recovery. The topic therefore connects transplantation biology with regenerative medicine and the development of cell-based treatments.
Engraftment research helps improve strategies for treating liver failure and inherited metabolic disorders by linking transplantation outcomes with tissue integration and metabolic function. Researchers can use evidence of retention, vascular connection, and restored activity to evaluate candidate therapies. This information supports refinement of approaches intended to replace or supplement impaired liver function.